This vaccine represents a paradigm shift in the fact that this is the first pre-exposure vaccine to target prevention of TB infection. The project was recently showcased by EU (EDCTP) on the World TB day. It is funded by RCN-GLOBVAC and the project is coordinated from K2 by Harleen Grewal. It is every reason to congratulate, Harleen!

http://www.edctp.org/news/world-tb-day-2017-closing-gaps-end-tuberculosis/